Mandatory Guidelines for Federal Workplace Drug Testing Programs-Authorized Testing Panels
Built by the Tribune's code from the Federal Register. No AI wrote this page. Published in the Federal Register March 13, 2026. Document 2026-04981. Updated Nov. 13, 2026.
- What it does
HHS herein publishes the panels of Schedule I and II drugs and biomarkers authorized for testing in federal workplace drug testing programs. The Department has made no revisions to the current drug testing panels for both urine and oral fluid and current required nomenclature for laboratory and Medical Review Officer Reports, effective July 7, 2025.
The Health and Human Services Department's summary, as published in the Federal Register.
- Compared with
The Health and Human Services Department has published 11 final rules in 2026 so far, compared with 13 in all of 2025.
Counted by the Tribune from Federal Register records since Jan. 1, 2025.
- What happens next and when
The current authorized drug testing panels and required report nomenclature remain in effect.
The agency's dates, word for word.
- Check it yourself
The record as published
| Document number | 2026-04981 |
|---|---|
| Action | Issuance of authorized drug testing panels. |
| Agencies | Health and Human Services Department |
| Published | March 13, 2026 |
Source: the Federal Register (public domain). The document in the Federal Register